In tumors with amplified MYCN, CLU is strongly downregulated, in part through transcriptional induction of miR-17-92, and it was demonstrated that mice with deregulated CLU are more prone to the formation of neuroblastomas [86]. The gene discussed is CLU; the disease is neuroblastoma.